期刊文献+

空腹血糖水平对冠心病患者核素心肌代谢显像质量的影响 被引量:5

Effects of fasting blood glucose levels on the quality of radionuclide imaging of myocardial metabolism in patients with coronary heart disease
原文传递
导出
摘要 目的探讨空腹血糖水平对冠心病患者正电子发射断层扫描显像/X射线计算机体层扫描(PET/CT)心肌代谢显像质量的影响。方法回顾分析2019至2020年在北京安贞医院完成18F-脱氧葡萄糖(18F-FDG)PET/CT心肌代谢显像检查的78例冠心病患者的资料,64例符合入选标准。所有患者禁食8 h以上,口服葡萄糖后静脉注射胰岛素和显像剂18F-FDG,完成心肌代谢图像采集。心肌代谢图像质量不影响临床诊断为合格,图像质量评分(IQ)0~2分;否则为不合格,评分为3~4分。分析比较合格组(55例)与不合格组(19例)患者性别、年龄、糖尿病患病率、体质指数、空腹血糖、糖化血红蛋白、糖化血清白蛋白、三酰甘油、游离脂肪酸以及服用调脂药、口服降糖药等差异及其影响因素。结果心肌代谢显像不合格组的糖尿病患病率高于合格组(63.2%和33.3%,χ^(2)=4.872,P=0.027)。不合格组患者空腹血糖、糖化血红蛋白及糖化血清白蛋白水平较合格组升高[7.67(6.02,11.64)和5.52(4.97,6.37)mmol/L;7.30(6.43,8.70)和6.20(5.60,6.87)%;19.8(15.1,24.1)和14.8(13.9,16.8)%,U=-3.909、-2.419和-3.042,P<0.001,P=0.016和0.002]。多因素Logistic回归分析显示空腹血糖是18F-FDG PET/CT心肌代谢显像质量不合格的独立危险因素,OR值1.62(95%CI:1.19~2.20,P=0.002)。空腹血糖≥6.66 mmol/L则是心肌显像不合格的ROC曲线下面积为0.81(95%CI:0.69~0.93,P<0.001)。结论空腹血糖水平是影响18F-FDG PET/CT心肌代谢显像质量的独立危险因素,糖尿病患者应积极控制血糖。 Objective To investigate the effects of fasting blood glucose levels on the quality of myocardial metabolism imaging via positron emission tomography/X-ray computed tomography(PET/CT)in patients with coronary heart disease.Methods A total of 78 patients with coronary heart disease from 2019 to 2020 undergone 18-fluorine deoxyglucose(18F-FDG)PET/CT myocardial imaging in Beijing Anzhen Hospital were retrospectively analyzed,with 64 patients meeting the inclusion criteria eventually enrolled in this study.All patients fasted over 8 hours and were injected with insulin and 18F-FDG following an oral glucose load.Then myocardial imaging evaluations were performed.Depending on whether the myocardial image quality(IQ)offered a match with clinical diagnosis,a score between 0-2 from the semiquantitative scoring system was defined as good IQ,while a score between 3-4 defined as poor IQ.Differences in sex,age,rate of diabetes,body mass index,fasting blood glucose(FBG),glycosylated hemoglobin,glycosylated serum albumin,triglycerides and free fatty acids,lipid-regulating drugs,and oral antidiabetic medications were analyzed between the good(n=55)and poor(n=19)image groups,and risk factors were examined.Results The diabetes mellitus rate was higher in the poor group than in the good group(63.2%vs.33.3%,χ^(2)=4.872,P=0.027).FBG,glycosylated hemoglobin and glycosylated serum albumin levels in the poor group were increased compared with the good group[7.67(6.02,11.64)mmol/L vs.5.52(4.97,6.37)mmol/L,7.30(6.43,8.70)%vs.6.20(5.60,6.87)%,19.8(15.1,24.1)%vs.14.8(13.9,16.8)%,U=-3.909,-2.419 and-3.042,P<0.001,P=0.016 and 0.002,respectively].Multivariate Logistic regression analysis showed that FBG was an independent risk factor for poor imaging(OR=1.62,95%CI:1.19-2.20,P=0.002).The area under the receiver operator characteristic(ROC)curve for FBG was 0.811(95%CI:0.69-0.93,P<0.001),and the cut-off value for FBG was 6.66 mmol/L.Conclusions FBG is an independent risk factor for myocardial image quality.Patients with diabetes mellitus should rigorously control their blood glucose levels.
作者 史晓鹏 周迎生 张晓丽 Shi Xiaopeng;Zhou Yingsheng;Zhang Xiaoli(Department of Endocrinology and Metabolism,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China;Department of Nuclear Medicine,Laboratory for Molecular Imaging,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China)
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2021年第5期596-600,共5页 Chinese Journal of Geriatrics
基金 国家自然科学基金(81641027) 北京市科技计划(Z131100004013044) 北京市学科带头人基金资助项目(2013-2-006) 北京市朝阳区科学技术和信息化局(CYSF1921)。
关键词 血糖 冠状动脉疾病 脱氧葡萄糖 Blood glucose Coronary artery disease Deoxyglucose
  • 相关文献

参考文献6

二级参考文献25

  • 1沈锐,刘秀杰,史蓉芳,田月琴,魏红星,郭风,何作祥.氧甲吡嗪在糖尿病患者^(18)F-FDG心肌代谢显像中的作用[J].中华核医学杂志,2005,25(4):224-227. 被引量:10
  • 2刘幼硕.老年人糖尿病的流行病学病因和临床特点[J].中华老年医学杂志,2005,24(9):718-719. 被引量:40
  • 3Larsen TS,Aasum E. Metabolic (in)flexibility of the diabetic heart. Cardiovasc Drugs Ther, 2008, 22: 91-95.
  • 4] Coort SL,Bonen A, van der Vusse GJ, et al. Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: role of sarcolemmal substrate transporters. Mol Cell Biochem, 2007, 299: 5-18.
  • 5Dutka DP, Pitt M, Pagano D, et al. Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease. J Am Coll Cardiol, 2006, 48:2225-2231.
  • 6Yokoyama I, Yonekura K, Ohtake T, et al. Role of insulin resistance in heart and skeletal muscle F-18 fluorodeoxyglueose uptake in patients with non-insulin-dependent diabetes mellitus. J Nuct Cardiol, 2000, 7: 242-248.
  • 7Bax JJ, Visser FC, Raymakers PG, et al. Cardiac ^18F-FDG-SPET studies in patients with non-insulin -dependent diabetes mellitus during hyperinsulinaemie euglycaemic clamping. Nucl Med Commun, 1997, 18: 200-206.
  • 8Schinkel AF, Bax JJ, Valkema R, et al. Effect of diabetes mellitus on myocardial ^18F-FDG SPECT using acipimox for the assessment of myocardial viability. J Nucl Med, 2003, 44: 877-883.
  • 9Aasum E, Cooper M, Severson DL, et al. Effect of BM 17. 0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice. Can J Physiol Pharmacol, 2005, 83= 183-190.
  • 10Naoumova RP, Khan MT, Kindler H, et al. Pioglitazone improves myocardial blood flow and glucose utilization in nondiabetic patients with combined hyperlipidemia. J Am College Cardi, 2007, 50, 2051-2058.

共引文献1074

同被引文献30

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部